Veopoz
Veopoz
CHAPLE is a rare inherited immune disorder leading to protein loss and intestinal issues. Browse therapies and medications used in managing CHAPLE syndrome.
Compare prices and save on your Cd55 Deficient Protein Losing Enteropathy Chaple prescription
Search for your Cd55 Deficient Protein Losing Enteropathy Chaple medication above or use our drug search.
See prices at pharmacies near you and find the lowest price available.
Download or print your coupon and show it at the pharmacy to save.
U.S. Food and Drug Administration (FDA). (2024). FDA Approves First Treatment for CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease) . U.S. Food and Drug Administration.
National Center for Biotechnology Information (NCBI). (2021). CD55 Deficiency (CHAPLE Disease): Pathophysiology and Clinical Management . PubMed Central (Peer-Reviewed Article).
Orphanet Journal of Rare Diseases. (2024). CD55 Deficiency (CHAPLE Disease): Epidemiology and Clinical Insights . Orphanet Journal of Rare Diseases.